Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 avr. 2015 16h05 HE | Source: CareDx, Inc.

CareDx to Present New Data on AlloMap(R) and Cell-Free DNA (cfDNA) Biomarker in Heart Transplant Recipients at ISHLT 2015

BRISBANE, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
17 mars 2015 16h05 HE | Source: CareDx, Inc.

CareDx, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results

BRISBANE, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
03 mars 2015 16h05 HE | Source: CareDx, Inc.

CareDx to Release Fourth Quarter 2014 Financial Results and Host Conference Call on March 17, 2015

BRISBANE, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
03 mars 2015 16h05 HE | Source: CareDx, Inc.

CareDx Appoints William A. Hagstrom to Its Board of Directors

BRISBANE, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
05 févr. 2015 08h05 HE | Source: CareDx, Inc.

CareDx to Present at Upcoming Investor Conferences

BRISBANE, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
03 févr. 2015 16h08 HE | Source: CareDx, Inc.

CareDx Secures $20 Million Term Loan With East West Bank, Replacing Existing Credit Facility

BRISBANE, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
12 janv. 2015 08h05 HE | Source: CareDx, Inc.

CareDx Announces Its Commercial European Partner Diaxonhit Has Selected Strasbourg University Hospital to Perform AlloMap(R) Testing in Europe

BRISBANE, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
07 janv. 2015 08h00 HE | Source: CareDx, Inc.

CareDx Receives Positive Coverage Decision for AlloMap(R) From Two Additional Medicare Administrative Carrier Jurisdictions

BRISBANE, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
05 janv. 2015 08h00 HE | Source: CareDx, Inc.

CareDx Appoints John J. Sninsky, Ph.D. as Chief Scientific Officer

BRISBANE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
12 déc. 2014 16h50 HE | Source: CareDx, Inc.

CareDx Presents HeartBrothers Foundation with a Grant to Support Heart Transplant Education and Patient Support in New England

BRISBANE, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...

Page précédente